Export to Excel Export to OpenOffice.org Print version

Novo Nordisk A/S (NVO) | Analysis of Revenues

Revenue Recognition Accounting Policy

Sales are measured at the fair value of the consideration received or receivable. Sales are reduced for realised and estimated customer returns, rebates and other similar allowances.

Revenue from the sale of goods is recognised when all the following conditions are satisfied:

  1. Novo Nordisk has transferred to the buyer the significant risks and rewards of ownership of the goods.
  2. Novo Nordisk retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold.
  3. The amount of revenue can be measured reliably.
  4. It is probable that the economic benefits associated with the transaction will flow to the entity.
  5. The costs incurred or to be incurred in respect of the transaction can be measured reliably.

Provisions for rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed care and other customers are recorded as a reduction of revenue at the time the related revenues are recorded or when the incentives are offered. They are calculated on the basis of historical experience and the specific terms in the individual agreements. The sales rebate accruals and provisions are included in Other current liabilities and Provisions for other liabilities.

Where there is historical experience or a reasonably accurate estimate of expected future returns can otherwise be made, a provision for estimated sales returns is recorded. Revenue recognition for new product launches is based on specific facts and circumstances relating to those products, including estimated demand and acceptance rates for well-established products with similar market characteristics. Where shipments of new or existing products are made on a sale or return basis, without sufficient historical experience for estimating sales returns, revenue is only recorded when there is evidence of consumption or when the right of return has expired.

Provisions for revenue deductions are adjusted to actual amounts as rebates, discounts and returns are processed.

Source: Novo Nordisk A/S, Annual Report

Revenues as Reported

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Novo Nordisk A/S, Income Statement, Revenues

USD $ in millions, translated from DKK kr

Export to Excel Export to OpenOffice.org
  12 months ended Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
chart Diabetes care
chart Biopharmaceuticals
chart Sales

Source: Novo Nordisk A/S Annual Reports

Item Description The company
Sales Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Novo Nordisk A/S's sales increased from 2009 to 2010 and from 2010 to 2011.

May 23, 2012

Existing users sign in

Forgot your password?